Report on the collection of under co-payment data 2018-19

17 December 2019 - The report on the collection of under co-payment data 2018-19 is now available. ...

Read more →

Lamotrigine NPPA change

17 December 2019 - The request seeks all ‘communications’ between members of the PHARMAC senior leadership team, and in anticipation ...

Read more →

Alberta changes coverage of biologic drugs for people with Crohn's, diabetes, arthritis

12 December 2019 - The provincial government says will free up hundreds of millions of dollars in health funding during the ...

Read more →

Canadian study shows substantial savings possible with use of biosimilar filgrastim

12 December 2019 - During this week’s annual meeting of American Society of Hematology, researchers from Canada reported that using biosimilar ...

Read more →

Alberta will force patients to switch from biologics to cheaper biosimilar medications

12 December 2019 - Alberta will force 26,000 patients on government-sponsored drug plans to switch from expensive drugs that are known ...

Read more →

Is it time to look beyond price with biosimilars?

5 December 2019 - While there is no question that falling prices that come with competition are cause for optimism in ...

Read more →

Top 10 drugs 2018–19

2 December 2019 - Rosuvastatin calcium (Crestor) was the top PBS/RPBS drug by prescription counts. ...

Read more →

Pricing tactics slow uptake of generic drugs by Medicare plans

21 November 2019 - Study finds new copycat medicines take years to win coverage. ...

Read more →

Biosimilars make progress in the Canadian market, but stakeholders see more work ahead

18 November 2019 - While much attention over the past few weeks has been on the US biosimilars market, with its ...

Read more →

Epilepsy NZ calls for halt to drug switch following deaths of three people

13 November 2019 - Epilepsy New Zealand is urging authorities to immediately halt a drug switch following the death of ...

Read more →

Drug Utilisation Sub-Committee outcome statement

13 November 2019 - The outcome statement from the October 2019 Drug Utilisation Sub-Committee meeting is now available. ...

Read more →

Biosimilars in the UK: where are we now and where does the NHS want to go?

9 October 2019 - The UK health service has well over a decade’s experience of dealing with biosimilars, but the ...

Read more →

Prescription opioid dispensing in Australian children and adolescents: a national population-based study

8 October 2019 - There are few population-based studies of paediatric opioid use.  ...

Read more →

Two more bills aiming to boost biosimilars introduced in Congress

23 September 2019 - Two biosimilar bills, both with bipartisan sponsors, were unveiled last week and aim to boost uptake in ...

Read more →

Xanax still being overprescribed despite policy changes

19 September 2019 - Patients are still being prescribed hundreds of Xanax tablets a year despite a cut in government ...

Read more →